Literature DB >> 12552112

Structural evidence for substrate strain in antibody catalysis.

Jun Yin1, Scott E Andryski, Albert E Beuscher, Raymond C Stevens, Peter G Schultz.   

Abstract

The crystal structure of the Michaelis complex between the Fab fragment of ferrochelatase antibody 7G12 and its substrate mesoporphyrin has been solved to 2.6-A resolution. The antibody-bound mesoporphyrin clearly adopts a nonplanar conformation and reveals that the antibody catalyzes the porphyrin metallation reaction by straining/distorting the bound substrate toward the transition-state configuration. The crystal structures of the Fab fragment of the germ-line precursor antibody to 7G12 and its complex with the hapten N-methylmesoporphyrin have also been solved. A comparison of these structures with the corresponding structures of the affinity-matured antibody 7G12 reveals the molecular mechanism by which the immune system evolves binding energy to catalyze this reaction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552112      PMCID: PMC298691          DOI: 10.1073/pnas.0235873100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Rapid automated molecular replacement by evolutionary search.

Authors:  C R Kissinger; D K Gehlhaar; D B Fogel
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-02

2.  A comparative analysis of the immunological evolution of antibody 28B4.

Authors:  J Yin; E C Mundorff; P L Yang; K U Wendt; D Hanway; R C Stevens; P G Schultz
Journal:  Biochemistry       Date:  2001-09-11       Impact factor: 3.162

Review 3.  The chemistry of the antibody molecule.

Authors:  Peter G Schultz; Jun Yin; Richard A Lerner
Journal:  Angew Chem Int Ed Engl       Date:  2002-12-02       Impact factor: 15.336

4.  Conformational effects in biological catalysis: an antibody-catalyzed oxy-cope rearrangement.

Authors:  E C Mundorff; M A Hanson; A Varvak; H Ulrich; P G Schultz; R C Stevens
Journal:  Biochemistry       Date:  2000-02-01       Impact factor: 3.162

5.  An unexpectedly efficient catalytic antibody operating by ping-pong and induced fit mechanisms.

Authors:  P Wirsching; J A Ashley; S J Benkovic; K D Janda; R A Lerner
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

6.  Application of a Theory of Enzyme Specificity to Protein Synthesis.

Authors:  D E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1958-02       Impact factor: 11.205

7.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

8.  Raster3D: photorealistic molecular graphics.

Authors:  E A Merritt; D J Bacon
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

9.  An efficient antibody-catalyzed aminoacylation reaction.

Authors:  J R Jacobsen; J R Prudent; L Kochersperger; S Yonkovich; P G Schultz
Journal:  Science       Date:  1992-04-17       Impact factor: 47.728

Review 10.  Ferrochelatase at the millennium: structures, mechanisms and [2Fe-2S] clusters.

Authors:  H A Dailey; T A Dailey; C K Wu; A E Medlock; K F Wang; J P Rose; B C Wang
Journal:  Cell Mol Life Sci       Date:  2000-12       Impact factor: 9.261

View more
  12 in total

1.  Modulation of inhibition of ferrochelatase by N-methylprotoporphyrin.

Authors:  Zhen Shi; Gloria C Ferreira
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

2.  Chelatases: distort to select?

Authors:  Salam Al-Karadaghi; Ricardo Franco; Mats Hansson; John A Shelnutt; Grazia Isaya; Gloria C Ferreira
Journal:  Trends Biochem Sci       Date:  2006-02-15       Impact factor: 13.807

3.  Somatic hypermutation maintains antibody thermodynamic stability during affinity maturation.

Authors:  Feng Wang; Shiladitya Sen; Yong Zhang; Insha Ahmad; Xueyong Zhu; Ian A Wilson; Vaughn V Smider; Thomas J Magliery; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

4.  Therapeutic Antibodies to Ganglioside GD2 Evolved from Highly Selective Germline Antibodies.

Authors:  Eric Sterner; Megan L Peach; Marc C Nicklaus; Jeffrey C Gildersleeve
Journal:  Cell Rep       Date:  2017-08-15       Impact factor: 9.423

5.  Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding.

Authors:  Yongjun Guan; Marzena Pazgier; Mohammad M Sajadi; Roberta Kamin-Lewis; Salma Al-Darmarki; Robin Flinko; Elena Lovo; Xueji Wu; James E Robinson; Michael S Seaman; Timothy R Fouts; Robert C Gallo; Anthony L DeVico; George K Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-13       Impact factor: 11.205

6.  Nickel(II) chelatase variants directly evolved from murine ferrochelatase: porphyrin distortion and kinetic mechanism.

Authors:  Neil R McIntyre; Ricardo Franco; John A Shelnutt; Gloria C Ferreira
Journal:  Biochemistry       Date:  2011-02-10       Impact factor: 3.162

7.  Structure and Dynamics of Stacking Interactions in an Antibody Binding Site.

Authors:  Ramkrishna Adhikary; Jörg Zimmermann; Robyn L Stanfield; Ian A Wilson; Wayne Yu; Masayuki Oda; Floyd E Romesberg
Journal:  Biochemistry       Date:  2019-06-19       Impact factor: 3.162

8.  Porphyrin binding and distortion and substrate specificity in the ferrochelatase reaction: the role of active site residues.

Authors:  Tobias Karlberg; Mattias D Hansson; Raymond K Yengo; Renzo Johansson; Hege O Thorvaldsen; Gloria C Ferreira; Mats Hansson; Salam Al-Karadaghi
Journal:  J Mol Biol       Date:  2008-03-28       Impact factor: 5.469

Review 9.  Synthesis at the interface of chemistry and biology.

Authors:  Xu Wu; Peter G Schultz
Journal:  J Am Chem Soc       Date:  2009-09-09       Impact factor: 15.419

10.  Multi-constraint computational design suggests that native sequences of germline antibody H3 loops are nearly optimal for conformational flexibility.

Authors:  Mariana Babor; Tanja Kortemme
Journal:  Proteins       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.